Is FDG PET-CT clinically and cost-effective for staging and/or restaging in patients with suspected renal or bladder cancer following an abnormal result on contrast-enhanced CT or MRI?
Healthcare Improvement Scotland.
Scottish Health Technologies Group.
"Produced by SHTG."
System requirements: Adobe Reader required to view PDF document.
Description from online resource; title from PDF caption title (Healthcare Improvement Scotland, viewed 4 June, 2019)
Kidneys
Bladder
Tomography, Emission